Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations

Jiun-Wen Guo1 Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Chung Kung University, Tainan, Taiwan

Yu-Hsuan Lee2 Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Hsiau-Wen Huang3 Food and Drug Administration, Ministry of Health and Welfare, Taiwan

Mei-Chyun Tzou3 Food and Drug Administration, Ministry of Health and Welfare, Taiwan

Ying-Jan Wang2 Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Jui-Chen Tsai1 Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Chung Kung University, Tainan, Taiwan;4 Center for Pharmaceutical Regulatory Science, National Cheng Kung University, Tainan, TaiwanCorrespondence[email protected]

Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations

Citations (8)

Articles from other publishers (8)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date